nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—rheumatoid arthritis—psoriasis	0.701	1	CtDrD
Penicillamine—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0872	0.463	CbGbCtD
Penicillamine—SLCO1B1—Cyclosporine—psoriasis	0.0661	0.351	CbGbCtD
Penicillamine—SLCO1B1—Methotrexate—psoriasis	0.035	0.186	CbGbCtD
Penicillamine—L-Threonine—TARS—psoriasis	0.00485	1	CrCbGaD
Penicillamine—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000118	0.00112	CcSEcCtD
Penicillamine—Asthma—Triamcinolone—psoriasis	0.000118	0.00111	CcSEcCtD
Penicillamine—Injury—Prednisone—psoriasis	0.000117	0.00111	CcSEcCtD
Penicillamine—Haematuria—Mycophenolate mofetil—psoriasis	0.000117	0.0011	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—psoriasis	0.000116	0.0011	CcSEcCtD
Penicillamine—Hepatobiliary disease—Mycophenolate mofetil—psoriasis	0.000116	0.00109	CcSEcCtD
Penicillamine—Diarrhoea—Calcitriol—psoriasis	0.000116	0.00109	CcSEcCtD
Penicillamine—Thrombocytopenia—Hydroxyurea—psoriasis	0.000116	0.00109	CcSEcCtD
Penicillamine—Pancreatitis—Triamcinolone—psoriasis	0.000115	0.00109	CcSEcCtD
Penicillamine—Skin disorder—Hydroxyurea—psoriasis	0.000115	0.00108	CcSEcCtD
Penicillamine—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000114	0.00108	CcSEcCtD
Penicillamine—Haemoglobin—Cyclosporine—psoriasis	0.000113	0.00107	CcSEcCtD
Penicillamine—Nausea—Methoxsalen—psoriasis	0.000113	0.00106	CcSEcCtD
Penicillamine—Haemorrhage—Cyclosporine—psoriasis	0.000113	0.00106	CcSEcCtD
Penicillamine—Anorexia—Hydroxyurea—psoriasis	0.000112	0.00106	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—psoriasis	0.000112	0.00106	CcSEcCtD
Penicillamine—Anaemia—Mycophenolic acid—psoriasis	0.000112	0.00106	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisolone—psoriasis	0.000112	0.00106	CcSEcCtD
Penicillamine—Agitation—Mycophenolic acid—psoriasis	0.000111	0.00105	CcSEcCtD
Penicillamine—Urinary tract disorder—Cyclosporine—psoriasis	0.000111	0.00105	CcSEcCtD
Penicillamine—Hypersensitivity—Acitretin—psoriasis	0.000111	0.00105	CcSEcCtD
Penicillamine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.00011	0.00104	CcSEcCtD
Penicillamine—Haemoglobin—Mycophenolate mofetil—psoriasis	0.00011	0.00104	CcSEcCtD
Penicillamine—Urethral disorder—Cyclosporine—psoriasis	0.00011	0.00104	CcSEcCtD
Penicillamine—Haemorrhage—Mycophenolate mofetil—psoriasis	0.00011	0.00104	CcSEcCtD
Penicillamine—Neuropathy peripheral—Hydrocortisone—psoriasis	0.000109	0.00103	CcSEcCtD
Penicillamine—Muscular weakness—Betamethasone—psoriasis	0.000109	0.00103	CcSEcCtD
Penicillamine—Muscular weakness—Dexamethasone—psoriasis	0.000109	0.00103	CcSEcCtD
Penicillamine—Urinary tract disorder—Mycophenolate mofetil—psoriasis	0.000108	0.00103	CcSEcCtD
Penicillamine—Leukopenia—Mycophenolic acid—psoriasis	0.000108	0.00102	CcSEcCtD
Penicillamine—Urethral disorder—Mycophenolate mofetil—psoriasis	0.000108	0.00102	CcSEcCtD
Penicillamine—Vomiting—Calcitriol—psoriasis	0.000107	0.00102	CcSEcCtD
Penicillamine—Rash—Calcitriol—psoriasis	0.000107	0.00101	CcSEcCtD
Penicillamine—Dermatitis—Calcitriol—psoriasis	0.000106	0.00101	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—psoriasis	0.000105	0.000996	CcSEcCtD
Penicillamine—Tinnitus—Cyclosporine—psoriasis	0.000105	0.000992	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—psoriasis	0.000104	0.000982	CcSEcCtD
Penicillamine—Arthralgia—Mycophenolic acid—psoriasis	0.000103	0.000975	CcSEcCtD
Penicillamine—Haemoglobin—Prednisolone—psoriasis	0.000103	0.000973	CcSEcCtD
Penicillamine—Diarrhoea—Acitretin—psoriasis	0.000103	0.000972	CcSEcCtD
Penicillamine—Neuropathy peripheral—Triamcinolone—psoriasis	0.000103	0.000972	CcSEcCtD
Penicillamine—Anxiety—Mycophenolic acid—psoriasis	0.000103	0.000971	CcSEcCtD
Penicillamine—Decreased appetite—Hydroxyurea—psoriasis	0.000103	0.00097	CcSEcCtD
Penicillamine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000103	0.00097	CcSEcCtD
Penicillamine—Haemorrhage—Prednisolone—psoriasis	0.000102	0.000968	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000102	0.000968	CcSEcCtD
Penicillamine—Tinnitus—Mycophenolate mofetil—psoriasis	0.000102	0.000968	CcSEcCtD
Penicillamine—Angiopathy—Cyclosporine—psoriasis	0.000102	0.000965	CcSEcCtD
Penicillamine—Haemoglobin—Hydrocortisone—psoriasis	0.000101	0.00095	CcSEcCtD
Penicillamine—Nausea—Calcitriol—psoriasis	0.0001	0.000949	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—psoriasis	0.0001	0.000946	CcSEcCtD
Penicillamine—Haemorrhage—Hydrocortisone—psoriasis	0.0001	0.000946	CcSEcCtD
Penicillamine—Angiopathy—Mycophenolate mofetil—psoriasis	9.96e-05	0.000942	CcSEcCtD
Penicillamine—Alopecia—Cyclosporine—psoriasis	9.94e-05	0.00094	CcSEcCtD
Penicillamine—Mental disorder—Cyclosporine—psoriasis	9.86e-05	0.000932	CcSEcCtD
Penicillamine—Alopecia—Mycophenolate mofetil—psoriasis	9.7e-05	0.000917	CcSEcCtD
Penicillamine—Thrombocytopenia—Mycophenolic acid—psoriasis	9.68e-05	0.000915	CcSEcCtD
Penicillamine—Mental disorder—Mycophenolate mofetil—psoriasis	9.62e-05	0.000909	CcSEcCtD
Penicillamine—Skin disorder—Mycophenolic acid—psoriasis	9.6e-05	0.000908	CcSEcCtD
Penicillamine—Dysgeusia—Cyclosporine—psoriasis	9.59e-05	0.000907	CcSEcCtD
Penicillamine—Vomiting—Acitretin—psoriasis	9.56e-05	0.000903	CcSEcCtD
Penicillamine—Vomiting—Fluocinolone Acetonide—psoriasis	9.53e-05	0.000901	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—psoriasis	9.53e-05	0.000901	CcSEcCtD
Penicillamine—Muscular weakness—Prednisone—psoriasis	9.49e-05	0.000897	CcSEcCtD
Penicillamine—Rash—Acitretin—psoriasis	9.48e-05	0.000896	CcSEcCtD
Penicillamine—Dermatitis—Acitretin—psoriasis	9.47e-05	0.000895	CcSEcCtD
Penicillamine—Haemoglobin—Triamcinolone—psoriasis	9.46e-05	0.000895	CcSEcCtD
Penicillamine—Rash—Fluocinolone Acetonide—psoriasis	9.45e-05	0.000893	CcSEcCtD
Penicillamine—Dermatitis—Fluocinolone Acetonide—psoriasis	9.44e-05	0.000893	CcSEcCtD
Penicillamine—Anorexia—Mycophenolic acid—psoriasis	9.42e-05	0.000891	CcSEcCtD
Penicillamine—Haemorrhage—Triamcinolone—psoriasis	9.42e-05	0.00089	CcSEcCtD
Penicillamine—Dysgeusia—Mycophenolate mofetil—psoriasis	9.36e-05	0.000885	CcSEcCtD
Penicillamine—Neuropathy peripheral—Betamethasone—psoriasis	9.33e-05	0.000882	CcSEcCtD
Penicillamine—Neuropathy peripheral—Dexamethasone—psoriasis	9.33e-05	0.000882	CcSEcCtD
Penicillamine—Body temperature increased—Hydroxyurea—psoriasis	9.33e-05	0.000882	CcSEcCtD
Penicillamine—Pancreatitis—Prednisone—psoriasis	9.11e-05	0.000862	CcSEcCtD
Penicillamine—Anaemia—Cyclosporine—psoriasis	9.05e-05	0.000856	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	9e-05	0.000851	CcSEcCtD
Penicillamine—Agitation—Cyclosporine—psoriasis	9e-05	0.000851	CcSEcCtD
Penicillamine—Nausea—Acitretin—psoriasis	8.93e-05	0.000844	CcSEcCtD
Penicillamine—Nausea—Fluocinolone Acetonide—psoriasis	8.9e-05	0.000842	CcSEcCtD
Penicillamine—Anaemia—Mycophenolate mofetil—psoriasis	8.83e-05	0.000835	CcSEcCtD
Penicillamine—Agitation—Mycophenolate mofetil—psoriasis	8.78e-05	0.00083	CcSEcCtD
Penicillamine—Leukopenia—Cyclosporine—psoriasis	8.77e-05	0.000829	CcSEcCtD
Penicillamine—Mental disorder—Hydrocortisone—psoriasis	8.76e-05	0.000828	CcSEcCtD
Penicillamine—Hypersensitivity—Hydroxyurea—psoriasis	8.69e-05	0.000822	CcSEcCtD
Penicillamine—Decreased appetite—Mycophenolic acid—psoriasis	8.59e-05	0.000812	CcSEcCtD
Penicillamine—Haemoglobin—Dexamethasone—psoriasis	8.59e-05	0.000812	CcSEcCtD
Penicillamine—Haemoglobin—Betamethasone—psoriasis	8.59e-05	0.000812	CcSEcCtD
Penicillamine—Leukopenia—Mycophenolate mofetil—psoriasis	8.55e-05	0.000809	CcSEcCtD
Penicillamine—Haemorrhage—Dexamethasone—psoriasis	8.54e-05	0.000808	CcSEcCtD
Penicillamine—Haemorrhage—Betamethasone—psoriasis	8.54e-05	0.000808	CcSEcCtD
Penicillamine—Arthralgia—Cyclosporine—psoriasis	8.34e-05	0.000789	CcSEcCtD
Penicillamine—Anxiety—Cyclosporine—psoriasis	8.31e-05	0.000786	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	8.28e-05	0.000783	CcSEcCtD
Penicillamine—Arthralgia—Mycophenolate mofetil—psoriasis	8.14e-05	0.000769	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisone—psoriasis	8.13e-05	0.000768	CcSEcCtD
Penicillamine—Anxiety—Mycophenolate mofetil—psoriasis	8.11e-05	0.000767	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—psoriasis	8.09e-05	0.000765	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	8.08e-05	0.000764	CcSEcCtD
Penicillamine—Diarrhoea—Hydroxyurea—psoriasis	8.07e-05	0.000763	CcSEcCtD
Penicillamine—Dysgeusia—Triamcinolone—psoriasis	8.03e-05	0.000759	CcSEcCtD
Penicillamine—Thrombocytopenia—Cyclosporine—psoriasis	7.83e-05	0.00074	CcSEcCtD
Penicillamine—Body temperature increased—Mycophenolic acid—psoriasis	7.81e-05	0.000739	CcSEcCtD
Penicillamine—Asthma—Methotrexate—psoriasis	7.77e-05	0.000735	CcSEcCtD
Penicillamine—Skin disorder—Cyclosporine—psoriasis	7.77e-05	0.000734	CcSEcCtD
Penicillamine—Angiopathy—Dexamethasone—psoriasis	7.75e-05	0.000733	CcSEcCtD
Penicillamine—Angiopathy—Betamethasone—psoriasis	7.75e-05	0.000733	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—psoriasis	7.69e-05	0.000727	CcSEcCtD
Penicillamine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	7.64e-05	0.000722	CcSEcCtD
Penicillamine—Anorexia—Cyclosporine—psoriasis	7.62e-05	0.000721	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—psoriasis	7.62e-05	0.00072	CcSEcCtD
Penicillamine—Skin disorder—Mycophenolate mofetil—psoriasis	7.58e-05	0.000716	CcSEcCtD
Penicillamine—Alopecia—Dexamethasone—psoriasis	7.55e-05	0.000714	CcSEcCtD
Penicillamine—Alopecia—Betamethasone—psoriasis	7.55e-05	0.000714	CcSEcCtD
Penicillamine—Vomiting—Hydroxyurea—psoriasis	7.5e-05	0.000709	CcSEcCtD
Penicillamine—Haemoglobin—Prednisone—psoriasis	7.48e-05	0.000707	CcSEcCtD
Penicillamine—Haemorrhage—Prednisone—psoriasis	7.44e-05	0.000704	CcSEcCtD
Penicillamine—Rash—Hydroxyurea—psoriasis	7.44e-05	0.000703	CcSEcCtD
Penicillamine—Anorexia—Mycophenolate mofetil—psoriasis	7.43e-05	0.000703	CcSEcCtD
Penicillamine—Dermatitis—Hydroxyurea—psoriasis	7.43e-05	0.000703	CcSEcCtD
Penicillamine—Anxiety—Hydrocortisone—psoriasis	7.39e-05	0.000698	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—psoriasis	7.38e-05	0.000698	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	7.36e-05	0.000696	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cyclosporine—psoriasis	7.28e-05	0.000689	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	7.11e-05	0.000672	CcSEcCtD
Penicillamine—Nausea—Hydroxyurea—psoriasis	7.01e-05	0.000663	CcSEcCtD
Penicillamine—Decreased appetite—Cyclosporine—psoriasis	6.95e-05	0.000657	CcSEcCtD
Penicillamine—Skin disorder—Hydrocortisone—psoriasis	6.9e-05	0.000653	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—psoriasis	6.81e-05	0.000644	CcSEcCtD
Penicillamine—Decreased appetite—Mycophenolate mofetil—psoriasis	6.78e-05	0.000641	CcSEcCtD
Penicillamine—Anorexia—Hydrocortisone—psoriasis	6.77e-05	0.00064	CcSEcCtD
Penicillamine—Diarrhoea—Mycophenolic acid—psoriasis	6.76e-05	0.000639	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—psoriasis	6.75e-05	0.000638	CcSEcCtD
Penicillamine—Angiopathy—Prednisone—psoriasis	6.75e-05	0.000638	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—psoriasis	6.61e-05	0.000625	CcSEcCtD
Penicillamine—Alopecia—Prednisone—psoriasis	6.58e-05	0.000622	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—psoriasis	6.55e-05	0.000619	CcSEcCtD
Penicillamine—Mental disorder—Prednisone—psoriasis	6.52e-05	0.000616	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	6.47e-05	0.000612	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—psoriasis	6.46e-05	0.000611	CcSEcCtD
Penicillamine—Urticaria—Cyclosporine—psoriasis	6.35e-05	0.000601	CcSEcCtD
Penicillamine—Body temperature increased—Cyclosporine—psoriasis	6.32e-05	0.000598	CcSEcCtD
Penicillamine—Anxiety—Dexamethasone—psoriasis	6.31e-05	0.000597	CcSEcCtD
Penicillamine—Anxiety—Betamethasone—psoriasis	6.31e-05	0.000597	CcSEcCtD
Penicillamine—Vomiting—Mycophenolic acid—psoriasis	6.28e-05	0.000594	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—psoriasis	6.25e-05	0.000591	CcSEcCtD
Penicillamine—Rash—Mycophenolic acid—psoriasis	6.23e-05	0.000589	CcSEcCtD
Penicillamine—Dermatitis—Mycophenolic acid—psoriasis	6.23e-05	0.000589	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—psoriasis	6.22e-05	0.000588	CcSEcCtD
Penicillamine—Urticaria—Mycophenolate mofetil—psoriasis	6.2e-05	0.000586	CcSEcCtD
Penicillamine—Decreased appetite—Hydrocortisone—psoriasis	6.18e-05	0.000584	CcSEcCtD
Penicillamine—Body temperature increased—Mycophenolate mofetil—psoriasis	6.17e-05	0.000583	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—psoriasis	6.14e-05	0.000581	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—psoriasis	6.1e-05	0.000576	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.1e-05	0.000576	CcSEcCtD
Penicillamine—Anaemia—Prednisone—psoriasis	5.99e-05	0.000566	CcSEcCtD
Penicillamine—Agitation—Prednisone—psoriasis	5.95e-05	0.000563	CcSEcCtD
Penicillamine—Thrombocytopenia—Dexamethasone—psoriasis	5.94e-05	0.000562	CcSEcCtD
Penicillamine—Thrombocytopenia—Betamethasone—psoriasis	5.94e-05	0.000562	CcSEcCtD
Penicillamine—Hypersensitivity—Cyclosporine—psoriasis	5.89e-05	0.000557	CcSEcCtD
Penicillamine—Nausea—Mycophenolic acid—psoriasis	5.87e-05	0.000555	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—psoriasis	5.8e-05	0.000548	CcSEcCtD
Penicillamine—Anorexia—Dexamethasone—psoriasis	5.79e-05	0.000547	CcSEcCtD
Penicillamine—Anorexia—Betamethasone—psoriasis	5.79e-05	0.000547	CcSEcCtD
Penicillamine—Urticaria—Prednisolone—psoriasis	5.78e-05	0.000546	CcSEcCtD
Penicillamine—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.75e-05	0.000543	CcSEcCtD
Penicillamine—Urticaria—Hydrocortisone—psoriasis	5.64e-05	0.000534	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—psoriasis	5.64e-05	0.000533	CcSEcCtD
Penicillamine—Body temperature increased—Hydrocortisone—psoriasis	5.62e-05	0.000531	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Betamethasone—psoriasis	5.53e-05	0.000523	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.53e-05	0.000523	CcSEcCtD
Penicillamine—Arthralgia—Prednisone—psoriasis	5.51e-05	0.000521	CcSEcCtD
Penicillamine—Anxiety—Prednisone—psoriasis	5.5e-05	0.00052	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—psoriasis	5.5e-05	0.00052	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.48e-05	0.000518	CcSEcCtD
Penicillamine—Diarrhoea—Cyclosporine—psoriasis	5.47e-05	0.000517	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—psoriasis	5.45e-05	0.000515	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisolone—psoriasis	5.36e-05	0.000507	CcSEcCtD
Penicillamine—Diarrhoea—Mycophenolate mofetil—psoriasis	5.34e-05	0.000505	CcSEcCtD
Penicillamine—Urticaria—Triamcinolone—psoriasis	5.32e-05	0.000503	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—psoriasis	5.3e-05	0.000501	CcSEcCtD
Penicillamine—Body temperature increased—Triamcinolone—psoriasis	5.29e-05	0.0005	CcSEcCtD
Penicillamine—Decreased appetite—Betamethasone—psoriasis	5.28e-05	0.000499	CcSEcCtD
Penicillamine—Decreased appetite—Dexamethasone—psoriasis	5.28e-05	0.000499	CcSEcCtD
Penicillamine—Hypersensitivity—Hydrocortisone—psoriasis	5.23e-05	0.000495	CcSEcCtD
Penicillamine—Skin disorder—Prednisone—psoriasis	5.14e-05	0.000486	CcSEcCtD
Penicillamine—Vomiting—Cyclosporine—psoriasis	5.08e-05	0.000481	CcSEcCtD
Penicillamine—Rash—Cyclosporine—psoriasis	5.04e-05	0.000477	CcSEcCtD
Penicillamine—Anorexia—Prednisone—psoriasis	5.04e-05	0.000476	CcSEcCtD
Penicillamine—Dermatitis—Cyclosporine—psoriasis	5.04e-05	0.000476	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—psoriasis	5e-05	0.000473	CcSEcCtD
Penicillamine—Vomiting—Mycophenolate mofetil—psoriasis	4.96e-05	0.000469	CcSEcCtD
Penicillamine—Hypersensitivity—Triamcinolone—psoriasis	4.93e-05	0.000466	CcSEcCtD
Penicillamine—Rash—Mycophenolate mofetil—psoriasis	4.92e-05	0.000465	CcSEcCtD
Penicillamine—Dermatitis—Mycophenolate mofetil—psoriasis	4.91e-05	0.000465	CcSEcCtD
Penicillamine—Diarrhoea—Hydrocortisone—psoriasis	4.86e-05	0.00046	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—psoriasis	4.85e-05	0.000458	CcSEcCtD
Penicillamine—Urticaria—Dexamethasone—psoriasis	4.82e-05	0.000456	CcSEcCtD
Penicillamine—Urticaria—Betamethasone—psoriasis	4.82e-05	0.000456	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Prednisone—psoriasis	4.82e-05	0.000455	CcSEcCtD
Penicillamine—Body temperature increased—Betamethasone—psoriasis	4.8e-05	0.000454	CcSEcCtD
Penicillamine—Body temperature increased—Dexamethasone—psoriasis	4.8e-05	0.000454	CcSEcCtD
Penicillamine—Nausea—Cyclosporine—psoriasis	4.75e-05	0.000449	CcSEcCtD
Penicillamine—Nausea—Mycophenolate mofetil—psoriasis	4.63e-05	0.000438	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—psoriasis	4.61e-05	0.000436	CcSEcCtD
Penicillamine—Decreased appetite—Prednisone—psoriasis	4.6e-05	0.000435	CcSEcCtD
Penicillamine—Rash—Prednisolone—psoriasis	4.59e-05	0.000434	CcSEcCtD
Penicillamine—Dermatitis—Prednisolone—psoriasis	4.58e-05	0.000433	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.58e-05	0.000433	CcSEcCtD
Penicillamine—Vomiting—Hydrocortisone—psoriasis	4.52e-05	0.000427	CcSEcCtD
Penicillamine—Rash—Hydrocortisone—psoriasis	4.48e-05	0.000424	CcSEcCtD
Penicillamine—Dermatitis—Hydrocortisone—psoriasis	4.48e-05	0.000423	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—psoriasis	4.33e-05	0.000409	CcSEcCtD
Penicillamine—Nausea—Prednisolone—psoriasis	4.32e-05	0.000409	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—psoriasis	4.29e-05	0.000406	CcSEcCtD
Penicillamine—Vomiting—Triamcinolone—psoriasis	4.25e-05	0.000402	CcSEcCtD
Penicillamine—Nausea—Hydrocortisone—psoriasis	4.22e-05	0.000399	CcSEcCtD
Penicillamine—Rash—Triamcinolone—psoriasis	4.22e-05	0.000399	CcSEcCtD
Penicillamine—Dermatitis—Triamcinolone—psoriasis	4.21e-05	0.000398	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—psoriasis	4.21e-05	0.000398	CcSEcCtD
Penicillamine—Urticaria—Prednisone—psoriasis	4.2e-05	0.000397	CcSEcCtD
Penicillamine—Body temperature increased—Prednisone—psoriasis	4.18e-05	0.000395	CcSEcCtD
Penicillamine—Diarrhoea—Betamethasone—psoriasis	4.15e-05	0.000393	CcSEcCtD
Penicillamine—Diarrhoea—Dexamethasone—psoriasis	4.15e-05	0.000393	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—psoriasis	4.03e-05	0.000381	CcSEcCtD
Penicillamine—Nausea—Triamcinolone—psoriasis	3.97e-05	0.000376	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisone—psoriasis	3.9e-05	0.000368	CcSEcCtD
Penicillamine—Vomiting—Betamethasone—psoriasis	3.86e-05	0.000365	CcSEcCtD
Penicillamine—Vomiting—Dexamethasone—psoriasis	3.86e-05	0.000365	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—psoriasis	3.84e-05	0.000363	CcSEcCtD
Penicillamine—Rash—Dexamethasone—psoriasis	3.83e-05	0.000362	CcSEcCtD
Penicillamine—Rash—Betamethasone—psoriasis	3.83e-05	0.000362	CcSEcCtD
Penicillamine—Dermatitis—Dexamethasone—psoriasis	3.82e-05	0.000362	CcSEcCtD
Penicillamine—Dermatitis—Betamethasone—psoriasis	3.82e-05	0.000362	CcSEcCtD
Penicillamine—Diarrhoea—Prednisone—psoriasis	3.62e-05	0.000342	CcSEcCtD
Penicillamine—Nausea—Betamethasone—psoriasis	3.61e-05	0.000341	CcSEcCtD
Penicillamine—Nausea—Dexamethasone—psoriasis	3.61e-05	0.000341	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—psoriasis	3.51e-05	0.000332	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—psoriasis	3.49e-05	0.00033	CcSEcCtD
Penicillamine—Vomiting—Prednisone—psoriasis	3.36e-05	0.000318	CcSEcCtD
Penicillamine—Rash—Prednisone—psoriasis	3.33e-05	0.000315	CcSEcCtD
Penicillamine—Dermatitis—Prednisone—psoriasis	3.33e-05	0.000315	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—psoriasis	3.26e-05	0.000308	CcSEcCtD
Penicillamine—Nausea—Prednisone—psoriasis	3.14e-05	0.000297	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—psoriasis	3.02e-05	0.000286	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—psoriasis	2.81e-05	0.000266	CcSEcCtD
Penicillamine—Rash—Methotrexate—psoriasis	2.79e-05	0.000263	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—psoriasis	2.78e-05	0.000263	CcSEcCtD
Penicillamine—Nausea—Methotrexate—psoriasis	2.62e-05	0.000248	CcSEcCtD
